Eandi, M. 2001. Fluvoxamina: profilo farmacoeconomico. Farmeconomia. Health economics and therapeutic pathways. 2, 3 (Sep. 2001), 175–184. DOI:https://doi.org/10.7175/fe.v2i3.731.